 Connection
Christina Chambers to Antidepressive Agents
This is a "connection" page, showing publications Christina Chambers has written about Antidepressive Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.095 |
|
|
|
-
Whaites Heinonen E, Johnson DL, Todd A, Chambers CD. Lower Adherence to Breastfeeding Recommendations in Mothers Treated With Antirheumatic and Antidepressant Medications. J Hum Lact. 2025 08; 41(3):412-422.
Score: 0.772
-
Whaites Heinonen E, Bertrand K, Chambers C. Macronutrients in Human Milk Exposed to Antidepressant and Anti-Inflammatory Medications. JAMA Netw Open. 2025 01 02; 8(1):e2453332.
Score: 0.751
-
Alwan S, Friedman JM, Chambers C. Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence. CNS Drugs. 2016 Jun; 30(6):499-515.
Score: 0.414
-
Bandoli G, Palmsten K, Flores KF, Chambers CD. Constructing Causal Diagrams for Common Perinatal Outcomes: Benefits, Limitations and Motivating Examples with Maternal Antidepressant Use in Pregnancy. Paediatr Perinat Epidemiol. 2016 09; 30(5):521-8.
Score: 0.412
-
Bandoli G, Chambers CD, Wells A, Palmsten K. Prenatal Antidepressant Use and Risk of Adverse Neonatal Outcomes. Pediatrics. 2020 07; 146(1).
Score: 0.137
-
Palmsten K, Chambers CD, Wells A, Bandoli G. Patterns of prenatal antidepressant exposure and risk of preeclampsia and postpartum haemorrhage. Paediatr Perinat Epidemiol. 2020 09; 34(5):597-606.
Score: 0.135
-
Bérard A, Sheehy O, Zhao JP, Chambers C, Roth M, Bozzo P, Johnson D, Kao K, Lavigne S, Wolfe L, Quinn D, Dieter K. Impact of antidepressant use, discontinuation, and dosage modification on maternal depression during pregnancy. Eur Neuropsychopharmacol. 2019 07; 29(7):803-812.
Score: 0.128
-
Bandoli G, Kuo GM, Sugathan R, Chambers CD, Rolland M, Palmsten K. Longitudinal trajectories of antidepressant use in pregnancy and the postnatal period. Arch Womens Ment Health. 2018 08; 21(4):411-419.
Score: 0.116
-
De Ocampo MPG, Araneta MRG, Macera CA, Alcaraz JE, Moore TR, Chambers CD. Risk of gestational hypertension and preeclampsia in women who discontinued or continued antidepressant medication use during pregnancy. Arch Womens Ment Health. 2016 12; 19(6):1051-1061.
Score: 0.105
-
Karam F, Sheehy O, Huneau MC, Chambers C, Fraser WD, Johnson D, Kao K, Martin B, Riordan SH, Roth M, St-André M, Lavigne SV, Wolfe L, Bérard A. Impact of maternal prenatal and parental postnatal stress on 1-year-old child development: results from the OTIS antidepressants in pregnancy study. Arch Womens Ment Health. 2016 10; 19(5):835-43.
Score: 0.102
-
Karam F, Sheehy O, Huneau MC, Chambers C, Fraser WD, Johnson D, Kao K, Martin BZ, Riordan SH, Roth M, St-André M, Lavigne SV, Wolfe L, Bérard A. The ASQ and R-PDQ telephone-administered validation within the OTIS antidepressant in pregnancy study. Psychol Assess. 2015 Dec; 27(4):1507-12.
Score: 0.024
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|